Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate
M F Pinard, J Jolivet, M Ratnam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 1999
Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study
C Cripps, M Burnell, J Jolivet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
The importance of dose scheduling with mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer
J Jolivet, K Bélanger, L Yelle, et al.
The Journal of Clinical Investigation
|
October 1, 1985
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate
G A Curt, J Jolivet, D N Carney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2005
Phase II study of troxacitabine in chemotherapy-naive patients with advanced cancer of the pancreas: gastrointestinal tumors
R Lapointe, R Létourneau, W Steward, et al.
The Journal of Clinical Investigation
|
September 1, 1985
Polyglutamation of methotrexate. Is methotrexate a prodrug?
B A Chabner, C J Allegra, G A Curt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1984
Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture
E Frei, A Rosowsky, J E Wright, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts
J A Houghton, L G Williams, S K Loftin, et al.
Clinical Colorectal Cancer
|
November 28, 2002
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian Trial
M Michael, D Hedley, A Oza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia
F J Giles, J E Cortes, S D Baker, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate
M F Pinard, J Jolivet, M Ratnam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 1999
Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study
C Cripps, M Burnell, J Jolivet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
The importance of dose scheduling with mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer
J Jolivet, K Bélanger, L Yelle, et al.
The Journal of Clinical Investigation
|
October 1, 1985
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate
G A Curt, J Jolivet, D N Carney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2005
Phase II study of troxacitabine in chemotherapy-naive patients with advanced cancer of the pancreas: gastrointestinal tumors
R Lapointe, R Létourneau, W Steward, et al.
The Journal of Clinical Investigation
|
September 1, 1985
Polyglutamation of methotrexate. Is methotrexate a prodrug?
B A Chabner, C J Allegra, G A Curt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1984
Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture
E Frei, A Rosowsky, J E Wright, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts
J A Houghton, L G Williams, S K Loftin, et al.
Clinical Colorectal Cancer
|
November 28, 2002
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian Trial
M Michael, D Hedley, A Oza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia
F J Giles, J E Cortes, S D Baker, et al.
Page
of 7